Skip to main content
. 2020 May 22;12:26. doi: 10.1186/s13099-020-00364-7

Table 1.

Clinical and laboratory characteristics of patients with CDI infected with ribotype 027 and other ribotypes

Ribotype 027 (N = 53)
n (%)
Other ribotypes (N = 11)
n (%)
p
2014/2015 (N = 45) 43 (95.6%) 2 (4.4%) < 0.001
2017/2018 (N = 19) 10 (52.6%) 9 (47.4%)
Age > 65 years 45 (84.9%) 8 (72.7%) 0.330
Fever 23 (43.3%) 3 (27.3%) 0.076
Abdominal cramps 44 (83%) 5 (45.5%) 0.007
Vomiting 9 (16.9%) 0 0.140
Abdominal distension 7 (13.2%) 1 (9%) 0.805
Hypotension 23 (43.4%) 6 (54.5%) 0.499
Initial number of stools (n) 1.67 ± 0.8 1.50 ± 0.7 0.766
Loose (mucoid) stools 44 (83%) 7 (63.4%) 0.325
CRP > 100 mg/l 21 (39.6%) 5 (45.5%) 0.353
WBC > 15 × 109/l 27 (50.9%) 1 (9%) 0.274
Albumin < 30 g/l 34 (64.1%) 7 (63.6%) 0.618
Ascites 7 (13.2%) 1 (9%) 0.707
Time to resolution of diarrhea (days) 5.5 ± 2.8 6.8 ± 4.8 0.275
Severe CDI 41 (77.3%) 4 (36.4%) 0.006
Severe, complicated CDI 5 (9.4%) 1 (0.9%) 1.000
First episode 29 (54.7%) 4 (36.4%) 0.637

WBC white blood cell count, CRP-C reactive protein